JEAN GOODWIN: Open Payments
NPI 1023342573 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 15 payments from 8 companies in 2025. Trend: 2023 $239 · 2024 $319 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $211 |
| Novo Nordisk Inc | 4 | $82 |
| Astellas Pharma US Inc | 1 | $30 |
| PFIZER INC. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: MOUNJARO, Veozah, JARDIANCE, ELIQUIS, FREESTYLE LIBRE 3, KEVEYIS, LEQVIO, Wegovy.
Industry payments across FL — which companies pay providers there.
